Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ivashkin VT"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-6 z 6
    Tytuł:
    Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial.
    Autorzy:
    Ivashkin VT; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
    Kudryavtseva AV; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.
    Krasnov GS; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.
    Poluektov YM; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.
    Morozova MA; Mental Health Research Center, Moscow, Russian Federation.
    Shifrin OS; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
    Beniashvili AG; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.
    Mamieva ZA; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
    Kovaleva AL; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
    Ulyanin AI; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
    Trush EA; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
    Erlykin AG; Moscow State Linguistic University, Moscow, Russian Federation.
    Poluektova EA; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2022 Jun 15; Vol. 17 (6), pp. e0263880. Date of Electronic Publication: 2022 Jun 15 (Print Publication: 2022).
    Typ publikacji:
    Journal Article; Randomized Controlled Trial
    MeSH Terms:
    Dyspepsia*
    Irritable Bowel Syndrome*
    Catechols ; Dietary Supplements ; Double-Blind Method ; Fatty Alcohols ; Humans ; Limonene ; Menthol/adverse effects ; RNA, Ribosomal, 16S ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT.
    Autorzy:
    Ivashkin VT; I.M. Sechenov First Moscow State Medical University (Sechenov University), 8-2, Trubetskaya St, 119991, Moscow, Russian Federation.
    Poluektova EA; I.M. Sechenov First Moscow State Medical University (Sechenov University), 8-2, Trubetskaya St, 119991, Moscow, Russian Federation.
    Glazunov AB; Department of Medical Information, Research and Production Company Materia Medica Holding LLC 'NPF' MATERIA MEDICA HOLDING, 9, 3rd Samotyochny Per, Moscow, Russian Federation, 127473. .
    Putilovskiy MA; Department of Medical Information, Research and Production Company Materia Medica Holding LLC 'NPF' MATERIA MEDICA HOLDING, 9, 3rd Samotyochny Per, Moscow, Russian Federation, 127473.
    Epstein OI; The Institute of General Pathology and Pathophysiology, 8, Baltiyskaya St, Moscow, Russian Federation, 125315.
    Pokaż więcej
    Źródło:
    BMC gastroenterology [BMC Gastroenterol] 2019 Dec 31; Vol. 20 (1), pp. 2. Date of Electronic Publication: 2019 Dec 31.
    Typ publikacji:
    Journal Article; Observational Study
    MeSH Terms:
    Antibodies/*therapeutic use
    Dyspepsia/*therapy
    Histamine/*immunology
    Immunotherapy/*methods
    Irritable Bowel Syndrome/*therapy
    S100 Proteins/*immunology
    Tumor Necrosis Factor-alpha/*immunology
    Adult ; Ambulatory Care ; Antibodies/adverse effects ; Drug Combinations ; Dyspepsia/complications ; Female ; Health Surveys/instrumentation ; Humans ; Immunotherapy/adverse effects ; Irritable Bowel Syndrome/complications ; Male ; Retrospective Studies ; Russia ; Severity of Illness Index ; Symptom Assessment/methods ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Prevalence of Clostridium Difficile-Associated Diarrhoea in Hospitalised Patients (Results of a Russian Prospective Multicentre Study).
    Autorzy:
    Dmitrieva NV; N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.
    Klyasova GA; National Research Center for Hematology, Moscow, Russia.
    Bakulina NV; North-Western State Medical University Named After I.I. Mechnikov, Saint-Petersburg, Russia.
    Sukhina MA; State Scientific Center of Coloproctology, Moscow, Russia.
    Zhuravel SV; N.V. Sklifosovsky Research Institute of Emergency Medicine, Moscow, Russia.
    Belousova EA; M.F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
    Ivashkin VT; I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
    Goryunov SV; City Clinical Hospital #15 Named After O.M. Filatov, Moscow, Russia.
    Prokhorovich EA; A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia.
    Kameneva TR; City Clinical Hospital Named After M.P. Konchalovskiy, Moscow, Russia.
    Samsonov AA; A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia.
    Yakovenko AV; Pirogov Russian National Research Medical University, Moscow, Russia.
    Kazakov SV; JSC 'Astellas Pharma', Moscow, Russia. .
    Pokaż więcej
    Źródło:
    Infectious diseases and therapy [Infect Dis Ther] 2018 Dec; Vol. 7 (4), pp. 523-534. Date of Electronic Publication: 2018 Sep 10.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Dose-Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light-Dark Test in Mice.
    Autorzy:
    Kardash EV; Research Institute of General Pathology and Pathophysiology, Moscow, Russian Federation.
    Ertuzun IA; OOO 'NPF 'Materia Medica Holding', Moscow, Russian Federation.
    Khakimova GR; OOO 'NPF 'Materia Medica Holding', Moscow, Russian Federation.
    Kolyadin AN; OOO 'NPF 'Materia Medica Holding', Moscow, Russian Federation.
    Tarasov SA; Research Institute of General Pathology and Pathophysiology, Moscow, Russian Federation.
    Wagner S; Neurofit SAS, Illkirch, France.
    Andriambeloson E; Neurofit SAS, Illkirch, France.
    Ivashkin VT; I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
    Epstein OI; Research Institute of General Pathology and Pathophysiology, Moscow, Russian Federation.
    Pokaż więcej
    Źródło:
    Dose-response : a publication of International Hormesis Society [Dose Response] 2018 Jun 26; Vol. 16 (2), pp. 1559325818779752. Date of Electronic Publication: 2018 Jun 26 (Print Publication: 2018).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-6 z 6

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies